Civica Rx and Xellia Pharmaceuticals have signed a product supply agreement under which Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems. Shortages of these anti-infective medications are impacting patient care in hospitals across the U.S.   The deal marks the first time that Civica is announcing the production of generic drugs—and the initial medications to be supplied—since the company was established to address chronic drug...